In the emerging US sports betting market, fierce competitors like FanDuel work together through the Sports Betting Alliance. They collaborate on lobbying and regulatory efforts because opening new states benefits the entire industry, embodying a "rising tide lifts all boats" strategy.

To influence policy on critical issues like the Priority Review Voucher, biotech CEOs are forming consortiums and going to Washington as a unified group. This collaborative approach is more effective than individual company efforts because it demonstrates a widespread industry problem that needs a legislative solution.

The Trump administration's strategy for lowering drug prices involves creating credible threats to bring companies to the negotiating table. This forces concessions and removes excess profit without crippling the industry's vital R&D capabilities.

Veteran advisor Bradley Tusk argues that successful startup lobbying is not about technology's merits, but about a politician's self-interest. The key is to demonstrate how approving the startup's agenda helps a politician win their next election, or how blocking it will hurt their chances.

When facing government pressure for deals that border on state capitalism, a single CEO gains little by taking a principled stand. Resisting alone will likely lead to their company being punished while competitors comply. The pragmatic move is to play along to ensure long-term survival, despite potential negative effects for the broader economy.

Contrary to their current stance, major AI labs will pivot to support national-level regulation. The motivation is strategic: a single, predictable federal framework is preferable to navigating an increasingly complex and contradictory patchwork of state-by-state AI laws, which stifles innovation and increases compliance costs.

A CEO reflects on why his firm was one of the few to sue over tariffs affecting an entire industry. He identifies a corporate bystander effect: when every company agrees a problem exists but assumes another will act, nobody does. This highlights the need for individual leadership to break collective inaction on industry-wide threats.

Beyond legislation and rulemaking, the government can act as a neutral convener, bringing together competing industry players to negotiate solutions to complex problems like lowering drug prices, bypassing legislative gridlock and lengthy legal battles.

When facing new regulation in emerging fields like prediction markets, DraftKings' CEO prioritizes building consensus within the industry first. He believes a unified industry voice is more effective in collaborating with regulators than individual companies pushing their own agendas.